View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Man Group PLC : Form 8.3 - Tritax Big Box REIT plc

Man Group PLC : Form 8.3 - Tritax Big Box REIT plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securi...

Imugene Limited: 1 director

A director at Imugene Limited sold 14,123,229 shares at 0.078AUD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Melco International Development: 1 director

A director at Melco International Development bought 1,900,000 shares at 5.137HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...

 PRESS RELEASE

Man Group PLC : Form 8.3 - International Paper Company

Man Group PLC : Form 8.3 - International Paper Company FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant se...

 PRESS RELEASE

Dime Community Bancshares, Inc. Reports First Quarter 2024 Results Wit...

Dime Community Bancshares, Inc. Reports First Quarter 2024 Results With Earnings Per Share Increasing By 11% Versus the Prior Quarter Core Deposit Growth of 19% Annualized Versus Year End Dime Has Been Executing on Growth Plan And Has Recruited Numerous Talented Groups of Bankers to Position Itself for Future Growth Capital Ratios Continue to Increase and Asset Quality Remains Stable HAUPPAUGE, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), today repor...

Chris Hoare
  • Chris Hoare

Nigerian Telcos Still weathering the (macro) storm

Nigerian telcos continue to perform well from a top line and KPIs perspective. Market service revenue growth accelerated in Q4 with both MTN and AAF growing underlying service revenue by 25% YoY.

 PRESS RELEASE

Man Group PLC : Form 8.3 - Tyman plc

Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this form...

 PRESS RELEASE

Hitachi Energy to invest additional $1.5 billion to ramp up global tra...

Hitachi Energy to invest additional $1.5 billion to ramp up global transformer production by 2027 Capacity expansion will increase speed to market to meet accelerating global demand, address long-term customer investments and create over 4,000 jobs -- Investments span across Europe, the Americas, and Asia leveraging existing global footprint -- Around $180 million in a new state-of-the-art transformer factory in Finland, a key location for clean technology development for renewables and industrial electrification Zurich, April 23, 2024 (GLOBE NEWSWIRE) -- Hitachi Energy today reveal...

 PRESS RELEASE

CorVel Announces New Integrations for Managed Care Services Enabling P...

CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience New integrations are propelled by technology that will create a best-in-class marketplace of services FORT WORTH, Texas, April 23, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, is announcing upcoming innovations to its managed care service offerings. Over the past year, CorVel has invested substantially in advanced technologies, particularly Generative AI. As a result, CorVel is pl...

Bell Food Group AG: 1 director

A director at Bell Food Group AG sold 100 shares at 276.000CHF and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Close Brothers Group: 2 directors

A director at Close Brothers Group bought 6,500 shares at 446p and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Mestron Holdings Berhad: 2 directors

Two Directors at Mestron Holdings Berhad sold 8,000,000 shares at 0.250MYR. The significance rating of the trade was 44/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

 PRESS RELEASE

Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024

Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024 GREAT NECK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: ) announced today that its net income for the three months ended March 31, 2024 was approximately $1,476,000, or $0.13 per share (based on approximately 11.4 million weighted-average outstanding common shares), compared to approximately $1,260,000, or $0.11 per share (based on approximately 11.5 million weighted-average outstanding common shares) for the three months ended March 31, 2023, an increase of $21...

 PRESS RELEASE

EQS-News: DER ACCUTOX ARM-002-IMPFSTOFF ZUR KREBSBEKÄMPFUNG FÜHRT ZU E...

EQS-News: Defence Therapeutics Inc. / Schlagwort(e): Sonstiges DER ACCUTOX ARM-002-IMPFSTOFF ZUR KREBSBEKÄMPFUNG FÜHRT ZU EINER HOCHWIRKSAMEN ANTIGENPRÄSENTATION 23.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Vancouver, British Columbia, Kanada, den 23. April 2024 - Defence Therapeutics Inc. („Defence“ oder das „Unternehmen“), (CSE: DTC, OTCQB: DTCFF, Börse Frankfurt: DTC), ein kanadisches Biotech-Unternehmen, das neuartige immunonkologische Therapeutika und Technologien zur Arzneimittelverabreichung entwickelt, fr...

 PRESS RELEASE

Lantronix to Participate in the 21st Annual Craig-Hallum Institutional...

Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024 IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions, today announced that Lantronix CEO Saleel Awsare and CFO Jeremy Whitaker will participate in one-on-one meetings with investors at the 21st Annual Craig-Hallum Institutional Investor Conference to be held on May 29, 2024, at the Depot Renaissance Hotel in Minneapolis. Interested investors should contact Lantronix CFO Jeremy Whitaker at for one-on-one meet...

 PRESS RELEASE

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Dis...

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results WALTHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2024 financial results on Tuesday, May 7, 2024, at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call . A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the compan...

Mezzion Pharma Co Ltd: 1 director

A director at Mezzion Pharma Co Ltd maiden bought 750 shares at 35,600.000KRW and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upreg...

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will present a poster at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting taking place in Baltimore, MD, May 7 – 11, 2024. The poster will feature new preclinical data that dem...

Ewa Manthey ... (+3)
  • Ewa Manthey
  • Lynn Song
  • Rebecca Byrne

Economics Live: China's Great Transition and what it means for metals ...

In this live webinar, we'll discuss the current headwinds facing China's economy as well as the major trends shaping its long-term growth potential. Sign-up now

 PRESS RELEASE

Mobilicom Launches Groundbreaking OS3 Operations System World’s First ...

Mobilicom Launches Groundbreaking OS3 Operations System World’s First for the Drones & Robotics Industry Software-as-a-Service (SaaS) designed to operate on NVIDIA AI computing for drones and roboticsOS3 enables unparalleled operational situational awareness, automated response, and mediation capabilities to neutralize malfunctions and threats across the operations stack from the drone and robot to the cloudMaximizes resilience to ensure financial performance of fleets for service providers, operators, and manufacturers Shoham, Israel, April 23, 2024 (GLOBE NEWSWIRE) --    Limited (Nasda...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch